UPM Pharmaceuticals is an independent, award-winning
CDMO. We o;er development and manufacturing of tablets,
capsules and semi-solid dosage forms – including DEA
controlled substances (CII–CV) and a controlled humidity
suite. At our 476,000 sq ft facility in Bristol, Tennessee, our
experienced personnel can advance your project from lab
scale to commercialization in a single location. Our excellent
quality record o;ers reassurance for success and speed
to clinic/market.